Home » News » World » Moderna Reports 'Robust' Covid Vaccine Response in Children Aged 6-11 Years
1-MIN READ

Moderna Reports 'Robust' Covid Vaccine Response in Children Aged 6-11 Years

Moderna says they are pleased that the study met its primary immunogenicity endpoints. (AFP)

Moderna says they are pleased that the study met its primary immunogenicity endpoints. (AFP)

Moderna says they are 'encouraged by the immunogenicity and safety profile of mRNA-1273 in children aged 6 to under 12 years'.

US pharmaceutical giant Moderna on Monday reported a “robust neutralising antibody response" to its Covid-19 vaccine in children aged 6-11, and said that it will submit the trial data to global regulators soon.

“We are encouraged by the immunogenicity and safety profile of mRNA-1273 in children aged 6 to under 12 years and are pleased that the study met its primary immunogenicity endpoints," chief executive Stephane Bancel said in a statement.

Read all the Latest News, Breaking News and Coronavirus News here. Follow us on Facebook, Twitter and Telegram.

first published:October 25, 2021, 18:52 IST